{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:48:55Z","timestamp":1789692535546,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.eplepsyres.2024.107476","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T23:32:28Z","timestamp":1731108748000},"page":"107476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Prevalence, clinical characteristics and outcomes of seizures in neurofibromatosis type 1: A systematic review and single arm meta-analysis"],"prefix":"10.1016","volume":"208","author":[{"given":"Fan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinna","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxiao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peidi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.eplepsyres.2024.107476_bib1","article-title":"Phenotype and genotype of saudi pediatric patients with neurofibromatosis type 1: a seven-year multicenter experience from Saudi Arabia","volume":"15","author":"Alfurayh","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.eplepsyres.2024.107476_bib2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2147\/JMDH.S454921","article-title":"Epidemiology and outcomes of neurofibromatosis type 1 (NF-1): multicenter tertiary experience","volume":"17","author":"Almuqbil","year":"2024","journal-title":"J. Multidiscip. Health"},{"issue":"10","key":"10.1016\/j.eplepsyres.2024.107476_bib3","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s10072-020-04400-x","article-title":"Neurological manifestations of neurofibromatosis: a review","volume":"41","author":"Bayat","year":"2020","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.eplepsyres.2024.107476_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000503831","article-title":"The epidemiology of epilepsy","volume":"54","author":"Beghi","year":"2020","journal-title":"Neuroepidemiology"},{"issue":"10","key":"10.1016\/j.eplepsyres.2024.107476_bib5","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s00381-020-04710-7","article-title":"Epilepsy in NF1: a systematic review of the literature","volume":"36","author":"Bernardo","year":"2020","journal-title":"Artic. Child'S. Nerv. Syst."},{"key":"10.1016\/j.eplepsyres.2024.107476_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.nicl.2014.04.005","article-title":"Characterizing the microstructural basis of \u201cunidentified bright objects\u201d in neurofibromatosis type 1: a combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysis","volume":"4","author":"Billiet","year":"2014","journal-title":"NeuroImage: Clin."},{"issue":"11","key":"10.1016\/j.eplepsyres.2024.107476_bib7","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s00381-022-05571-y","article-title":"Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1","volume":"38","author":"Cantor","year":"2022","journal-title":"Artic. Child'S. Nerv. Syst."},{"issue":"4","key":"10.1016\/j.eplepsyres.2024.107476_bib8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2024.107476_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejpn.2011.10.002","article-title":"Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images","volume":"16","author":"Ferraz-Filho","year":"2012","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"11","key":"10.1016\/j.eplepsyres.2024.107476_bib10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/14737175.2021.1915135","article-title":"Focal cortical dysplasia: an update on diagnosis and treatment","volume":"21","author":"Guerrini","year":"2021","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.eplepsyres.2024.107476_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2024.107336","article-title":"Epilepsy in neurofibromatosis type 1: prevalence, phenotype, and genotype in adults","volume":"202","author":"Hebert","year":"2024","journal-title":"Epilepsy Res"},{"issue":"8","key":"10.1016\/j.eplepsyres.2024.107476_bib12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.seizure.2011.04.016","article-title":"Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects","volume":"20","author":"Hsieh","year":"2011","journal-title":"Seizure"},{"issue":"12","key":"10.1016\/j.eplepsyres.2024.107476_bib13","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/epi.14596","article-title":"The epidemiology of drug-resistant epilepsy: a systematic review and meta-analysis","volume":"59","author":"Kalilani","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2024.107476_bib14","article-title":"Epilepsy and electroencephalogram characteristics in children with neurofibromatosis type 1, what we have learned from a tertiary center five years\u2019 experience","volume":"9","author":"Khair","year":"2022","journal-title":"Artic. Child Neurol. Open"},{"issue":"4","key":"10.1016\/j.eplepsyres.2024.107476_bib15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1528-1157.1993.tb00437.x","article-title":"Patterns of seizures observed in association with neurofibromatosis 1","volume":"34","author":"Korf","year":"1993","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.eplepsyres.2024.107476_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0887-8994(98)00075-7","article-title":"Seizures in neurofibromatosis 1","volume":"19","author":"Kulkantrakorn","year":"1998","journal-title":"Artic. Pediatr. Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2024.107476_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1474-4422(14)70255-8","article-title":"A multidisciplinary approach in neurofibromatosis 1","volume":"14","author":"Milani","year":"2015","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.eplepsyres.2024.107476_bib18","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-0660","article-title":"Health supervision for children with neurofibromatosis type 1","volume":"143","author":"Miller","year":"2019","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.eplepsyres.2024.107476_bib19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.amjmed.2021.01.038","article-title":"Epilepsy: a clinical overview","volume":"134","author":"Milligan","year":"2021","journal-title":"Am. J. Med"},{"key":"10.1016\/j.eplepsyres.2024.107476_bib20","article-title":"Chapter 7: systematic reviews of etiology and risk. JBI manual for evidence synthesis","author":"Moola","year":"2020","journal-title":"JBI"},{"issue":"5","key":"10.1016\/j.eplepsyres.2024.107476_bib21","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1007\/s12035-016-9907-1","article-title":"Sensitization of ion channels contributes to central and peripheral dysfunction in neurofibromatosis type 1","volume":"54","author":"Moutal","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2024.107476_bib22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00401-019-02002-2","article-title":"An update on the central nervous system manifestations of neurofibromatosis type 1","volume":"139","author":"Nix","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.eplepsyres.2024.107476_bib23","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.2174\/1570159X20666220706102708","article-title":"Epilepsy and cognitive impairment in childhood and adolescence: a mini-review","volume":"21","author":"Operto","year":"2023","journal-title":"Curr. Neuropharmacol."},{"issue":"10","key":"10.1016\/j.eplepsyres.2024.107476_bib24","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/epi.12348","article-title":"Epilepsy in individuals with neurofibromatosis type 1","volume":"54","author":"Ostendorf","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2024.107476_bib25","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.eplepsyres.2024.107476_bib26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/jnnp.2009.179630","article-title":"Brain structure and function in neurofibromatosis type 1: current concepts and future directions","volume":"81","author":"Payne","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2024.107476_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.yebeh.2017.05.011","article-title":"Epilepsy in neurofibromatosis type 1","volume":"73","author":"Pecoraro","year":"2017","journal-title":"Epilepsy Behav."},{"issue":"7","key":"10.1016\/j.eplepsyres.2024.107476_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15072109","article-title":"Evaluating focal areas of signal intensity (FASI) in children with neurofibromatosis type-1 (NF1) treated with selumetinib on pediatric brain tumor consortium (PBTC)-029B","volume":"15","author":"Pillay-Smiley","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.eplepsyres.2024.107476_bib29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/biomedicines11030651","article-title":"Efficacy and tolerability of perampanel in brain tumor-related epilepsy: a systematic review","volume":"11","author":"Rossi","year":"2023","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.eplepsyres.2024.107476_bib30","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3390\/cancers13081831","article-title":"Non-oncological neuroradiological manifestations in NF1 and their clinical implications","volume":"13","author":"Russo","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.eplepsyres.2024.107476_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13052-018-0477-x","article-title":"Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?","volume":"44","author":"Santoro","year":"2018","journal-title":"Ital. J. Pedia"},{"issue":"Pt A","key":"10.1016\/j.eplepsyres.2024.107476_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.yebeh.2019.06.022","article-title":"Epilepsy in neurofibromatosis type 1: diffuse cerebral dysfunction?","volume":"98","author":"Serdaroglu","year":"2019","journal-title":"Epilepsy Behav."},{"issue":"1","key":"10.1016\/j.eplepsyres.2024.107476_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26815\/acn.2020.00283","article-title":"Clinical characteristics of epilepsy and its risk factors in neurofibromatosis type 1: a single-center study","volume":"29","author":"Shin","year":"2021","journal-title":"Artic. Ann. Child Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2024.107476_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40478-020-00904-x","article-title":"Low-grade developmental and epilepsy associated brain tumors: a critical update 2020","volume":"8","author":"Slegers","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"issue":"7","key":"10.1016\/j.eplepsyres.2024.107476_bib35","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1007\/s00415-022-11008-y","article-title":"Cognitive disorders in childhood epilepsy: a comparative longitudinal study using administrative healthcare data","volume":"269","author":"Sorg","year":"2022","journal-title":"J. Neurol."},{"issue":"24","key":"10.1016\/j.eplepsyres.2024.107476_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246336","article-title":"Epilepsy in NF1: epidemiologic, genetic, and clinical features. a monocentric retrospective study in a cohort of 784 patients","volume":"13","author":"Sorrentino","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10.1016\/j.eplepsyres.2024.107476_bib37","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.eplepsyres.2024.107476_bib38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/08830738030180050501","article-title":"Epilepsy in neurofibromatosis 1","volume":"18","author":"Vivarelli","year":"2003","journal-title":"J. Child Neurol."},{"issue":"3","key":"10.1016\/j.eplepsyres.2024.107476_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-0035-1552618","article-title":"Hippocampal sclerosis: causes and prevention","volume":"35","author":"Walker","year":"2015","journal-title":"Semin Neurol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121124001918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121124001918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T17:42:41Z","timestamp":1732297361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121124001918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":39,"alternative-id":["S0920121124001918"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107476","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence, clinical characteristics and outcomes of seizures in neurofibromatosis type 1: A systematic review and single arm meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107476"}}